A Phase 1 clinical trial has investigated the effect of umbilical cord-derived MSCs on the immune systems of Lupus patients. Although the study was small, positive results were observed 24 weeks post-treatment.
A new study suggests that umbilical cord tissue could one day be used to treat chronic, non-healing diabetic foot ulcers. EpiCord, a thick membrane product produced from umbilical cords, has been studied and tested as a form of wound dressing and healing for the ulcers.
A joint US and Chinese clinical trial has successfully demonstrated dental tissue regrowth using stem cells from baby teeth. The Phase 1 trial suggests a promising solution to injury-caused tooth damage in children with young adult teeth.
Researchers at the Stowers Institute of Medical Research have found another way to expand/multiply blood-forming, adult stem cells from umbilical cord blood. The discovery increases the potential of a single stem cell sample in treating more conditions.
As more and more research highlights the benefits of delayed cord clamping, it’s understandable that umbilical cord blood stem cell banking raises many questions for parents-to-be. Here we explain how delayed cord clamping works alongside cord blood stem cell banking to help protect your baby’s health.